Media are invited to join patient representatives at the national release of the 2007 Wyatt Health International Comparison on Monday, September 15. This first of its kind study raises serious questions about the quality of Canada’s public drug plans and demonstrates that Canada ranks near the bottom of developed countries in terms of timeliness and access to the new innovative medicines.

The Wyatt Health International Comparison Study explored differing rates of public access since 2003 to the latest innovative medications for a range of serious illnesses in 18 developed countries including Canada, the U.S., parts of Europe and Australia and New Zealand.

The results will be unveiled in a brief presentation by George Wyatt followed by a question and answer session with patient representatives.

Mr. Wyatt will be available for media interviews following the briefing.

What:
Launch of the Wyatt Health International Comparison 2007

Who:
George Wyatt, Wyatt Health Management

When:
Monday, September 15, 2008
9:30 AM

Where:
Metropolitan Hotel
Toronto Ballroom, Second Floor
108 Chestnut Street
Toronto